A discussion on the risks of re-scheduling cannabinoids in the United States and the consequences of reclassifying marijuana with THC. The discussion also covers the harms and risks of marijuana use.
FDA Federal Register Submission for WHO Review and Consideration – On Cannabis Genotoxicity, General
Leave a reply
Your email address will not be published. Fields marked * are mandatory.